Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)



*Denotes required.


Don’t Derail Drug Development: 5 Common Issues to Identify and Avoid With a First-Rate Quality Process

Wed, Jun 14, 2023 11:00 AM EDT{LOCAL_TZ}

Event Overview

Quality encompasses adherence to regulatory compliance, which includes ensuring the safety and efficacy of pharmaceutical supplies, product development, and regulatory improvement, and maintaining an uninterrupted supply chain. In this webcast, Syner-G BioPharma Group’s Director of Quality Assurance and Compliance, Bryan Abney, will discuss the importance of identifying the most common issues that can derail drug development and will advise on how to avoid them while implementing and maintaining excellent Quality processes.

Key Learning Objectives

Attendees will learn:
  • The consequences of a derailed drug development program
  • The top 5 issues to be avoided
  • The importance and benefits of a strong Quality culture 
  • Why a company should consider partnering with consulting experts and when to seek support

Who Should Attend
  • C-Suite
  • Directors+
  • Small companies with very thin teams in the beginning stages of drug development
  • Small molecule, biologics, cell and gene therapy, medical device innovator


Featured Speakers

Bryan Abney
Bryan Abney
Vice President of Quality Assurance and Compliance
Syner-G BioPharma Group

Bryan Abney is the Vice President of Quality Assurance and Compliance and a member of the Syner-G team since March 2022. He is an experienced pharmaceutical Quality professional with 30 years of progressive experience directing quality control, analytical development and validation, product/process remediation, and quality assurance. His specialties include Analytical Chemistry, ICH and FDA guidelines, ANDA, and NDA. His main area of expertise is in Quality Management Systems.

Speaker’s Email:bryan.abney@synergbiopharma.com
Speaker’s LinkedIn: https://www.linkedin.com/in/bryan-abney-97771710/

Katie W. Winder
Katie W. Winder
Associate Director Quality and Compliance
Syner-G BioPharma Group

Katie W. Winder is the Associate Director of Quality and Compliance and has been a leader in the pharmaceutical cGMP environment for the past 17 years, helping to oversee responsibilities supporting Quality Assurance and Quality Control. Her responsibilities have included providing phase appropriate implementation or improvement in Quality Systems and guidance in decision making for Quality problems ranging by complexity to the industry based on her experience.

Speaker's Email: katie.winder@synergbiopharma.com
Speaker's LinkedIn:https://www.linkedin.com/in/katie-winder-2a1a81157/

For any technical questions please contact Jorge de la Bandera: JdelaBandera@mjhlifesciences.com